NuSkin Enterprises financials
$4.59−1.08%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B | $2.58B | $2.42B | $2.68B | $2.28B | $2.21B |
| Gross profit | $1.03B | $1.18B | $1.36B | $1.59B | $2.02B | $1.92B | $1.84B | $2.04B | $1.78B | $1.71B |
| Gross margin | 69.4% | 68.2% | 68.9% | 71.7% | 75.0% | 74.5% | 76.0% | 76.3% | 78.0% | 77.3% |
| Operating income | $65.8M | -$151.6M | $48.3M | $110.8M | $234.0M | $257.6M | $267.4M | $240.9M | $274.5M | $231.1M |
| Net income | $160.2M | -$146.6M | $8.6M | $104.8M | $147.3M | $191.4M | $173.6M | $121.9M | $129.4M | $143.1M |
| Net margin | 10.8% | −8.5% | 0.4% | 4.7% | 5.5% | 7.4% | 7.2% | 4.5% | 5.7% | 6.5% |
| Diluted EPS | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 | $3.63 | $3.10 | $2.16 | $2.36 | $2.55 |
| EBITDA | $143.1M | $120.6M | $139.0M | $231.8M | $410.9M | $377.7M | $388.5M | $394.5M | $346.0M | $303.5M |
| Operating cash flow | $80.3M | $111.7M | $118.6M | $108.1M | $141.6M | $379.1M | $177.9M | $202.7M | $302.6M | $275.3M |
| Free cash flow | $46.0M | $70.2M | $60.1M | $49.0M | $73.0M | $315.3M | $111.9M | $132.4M | $242.4M | $225.0M |
| Diluted shares | 50.3M | 49.7M | 49.9M | 50.5M | 51.4M | 52.8M | 55.9M | 56.5M | 54.9M | 56.1M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $238.6M | $186.9M | $256.1M | $264.7M | $339.6M | $402.7M |
| Short-term investments | $1.2M | $11.1M | $11.8M | $13.8M | $15.2M | $21.2M |
| Total debt | $224.2M | $393.6M | $503.0M | $402.5M | $376.3M | $335.4M |
| Total assets | $1.41B | $1.47B | $1.81B | $1.82B | $1.91B | $1.96B |
| Total liabilities | $600.1M | $817.5M | $986.7M | $923.7M | $993.7M | $1.06B |
| Shareholders' equity | $805.2M | $651.5M | $822.0M | $897.3M | $912.8M | $894.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology